App-Quantinova.ai

The Impact of Plasma Levels of Receptor for Advanced Glycation End-products and High Mobility Group Box 1 in Patients With Pulmonary Hypertension

Kazuhiko Nakazato - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Comparison of First-Generation and Second-Generation Drug Eluting Stents in Real-World Acute Coronary Syndrome Population - Data from Zabrze-Katowice Registry

Beata Morawiec - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

ZoMaxx

Trends in Venous Thromboembolism in Hospitalized Heart Failure Patients in the United States: Analysis of the 2002 to 2011 Nationwide Inpatient Sample Database

Dhaval Kolte - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Angiographic and Hemodynamic Features of Symptomatic Vertebrobasilar Disease: Baseline Data from the VERiTAS Study

Xinjian Du - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Temporal Trends in Incidence and Outcomes of Peripartum Cardiomyopathy in the United States: A Nationwide Population-Based Study

Sahil Khera - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Endogenous Superoxide Dismutase Protects From Impaired Generation of Activated Protein C and Enhanced Susceptibility to Experimental Thrombosis in Mice

Sean X Gu - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Superoxide dismutase

Endothelial LOX-1 Protects Against Arterial Thrombosis via Activation of the Oct-1/SIRT1 Pathway

Giovanni G Camici - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Suppression of Atherosclerosis by CD39

Matthew Hyman - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Iron Plays a Role in the Thrombus Formation of a Rat Model of Deep Vein Thrombosis

Yoshiro Naito - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Long Term Outcomes After Transcatheter and Surgerical Closure of Atrial Setpal Defect: Implications From National Populational Based Cohort Study in Propensity Score Matching

Yung Chuan Hsiao - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Impact of Out-stent Plaque Vulnerability on Neointimal Stent Coverage in Patients with Acute Coronary Syndrome: Intracoronary Angioscopic and Ultrasonic Quantification

Minoru Ichikawa - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Assessment of Optical Coherence Tomogaphic Findings between Cobalt-Chromium Everolimus-Eluting Stents and New Generation Drug-Eluting Stents

Hirofumi Ohtani - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Improved Clinical Outcomes of Patients Aged ?75 Years Treated with Drug-Eluting Stents Compared to Bare Metal Stents in Large Coronary Arteries: Results from the Basket-Prove Randomized Trail

Alain M Bernheim - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Which is Better, Biodegradable-polymer Coated Biolimus A9-eluting Stents or Biocompatible Durable-polymer Coated Everolimus-eluting Stents?: Serial Optical Coherence Tomographic Evaluation

Masami Nishino - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Biolimus A9

Peri-Procedural Anticoagulation Regimen Influences the Clinical Course of Migraine in Atrial Fibrillation Patients With or Without Pre-Existent Migraine

Prasant Mohanty - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Warfarin

Combined Effect of an Interleukin-6 Gene Variant and Smoking on Endothelial Function, Inflammatory and Thrombotic Processes and Prevalence of Coronary Artery Disease

Nikolaos Papageorgiou - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ILS-969

Evaluation of Medical Costs Avoided When New Oral Anticoagulants Are Used for Extended Treatment of Venous Thromboembolism Based on Clinical Trial Results

Yonghua Jing - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

rivaroxaban

The Combination of an Ostium Secundlum Type Atrial Septal Defect with a Pulmonary Arterial Thromboembolism Caused an Enlarged Pulmonary Artery, Pulmonary Hypertension and Recurrent Paradoxical Cerebral Embolism due to Deep Vein Thrombosis

Hiroyuki Takaoka - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Clopidogrel bisulfate

In-Stent Restenosis:Identification of a New Marker by Thrombelastography

Martin G Gesheff - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Hemostatic Solution

Structural Remodeling Determinants of Reduced Left Atrial Blood Flow Measured by 4D Flow MRI in Patients With Atrial Fibrillation

Michael Markl - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts